Journal article
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis
Abstract
BACKGROUND: Direct oral anticoagulants (DOACs) are recommended over vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant antiplatelet therapy may potentiate the antithrombotic effects of DOACs.
OBJECTIVES: We evaluated the impact of concomitant antiplatelet therapy on the efficacy and safety of DOACs.
Authors
Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
Journal
Journal of Thrombosis and Haemostasis, Vol. 18, No. 7, pp. 1661–1671
Publisher
Elsevier
Publication Date
July 2020
DOI
10.1111/jth.14807
ISSN
1538-7933